EPISODE · Nov 19, 2025 · 12 MIN
AMD 2023 Mar: Avacincaptad Pegol for Geographic Atrophy: GATHER1 18-Month Results
from Eye Research Deep Dive: Doctopus the Octometrist · host Dr Michael Nelson, OD FAAO
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialPatel SS, Lally DR, Hsu J, Wykoff CC, Eichenbaum D, Heier JS, Jaffe GJ, Westby K, Desai D, Zhu L, Khanani AM. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye (Lond). 2023 Dec;37(17):3551-3557. doi: 10.1038/s41433-023-02497-w. Epub 2023 Mar 24. Erratum in: Eye (Lond). 2023 Dec;37(17):3705. doi: 10.1038/s41433-023-02548-2. PMID: 36964259; PMCID: PMC10686386.https://pmc.ncbi.nlm.nih.gov/articles/PMC10686386/pdf/41433_2023_Article_2497.pdf
What this episode covers
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialPatel SS, Lally DR, Hsu J, Wykoff CC, Eichenbaum D, Heier JS, Jaffe GJ, Westby K, Desai D, Zhu L, Khanani AM. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye (Lond). 2023 Dec;37(17):3551-3557. doi: 10.1038/s41433-023-02497-w. Epub 2023 Mar 24. Erratum in: Eye (Lond). 2023 Dec;37(17):3705. doi: 10.1038/s41433-023-02548-2. PMID: 36964259; PMCID: PMC10686386.https://pmc.ncbi.nlm.nih.gov/articles/PMC10686386/pdf/41433_2023_Article_2497.pdf
NOW PLAYING
AMD 2023 Mar: Avacincaptad Pegol for Geographic Atrophy: GATHER1 18-Month Results
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m